Feed excerpt — reported by Inc.
As more consumers turn to GLP-1 medications, beauty brands see a lucrative opportunity. But not every product lives up to the hype.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Inc. →